Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Preferred Stock Liabilities (2019 - 2020)

Cellebrite DI (CLBT) has 1 years of Preferred Stock Liabilities data on record, last reported at $101.2 million in Q4 2020.

  • For Q4 2020, Preferred Stock Liabilities changed N/A year-over-year to $101.2 million; the TTM value through Dec 2020 reached $101.2 million, changed N/A, while the annual FY2020 figure was $101.2 million, 0.0% changed from the prior year.
  • Preferred Stock Liabilities reached $101.2 million in Q4 2020 per CLBT's latest filing.
  • Across five years, Preferred Stock Liabilities topped out at $101.2 million in Q4 2020 and bottomed at $101.2 million in Q4 2020.